These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 15487859

  • 1. [Weekly Fosamax tablet is significantly more effective than risedronate daily, as results of the Head-to-Head Study show].
    Praxis (Bern 1994); 2004 Sep 01; 93(36):1454. PubMed ID: 15487859
    [No Abstract] [Full Text] [Related]

  • 2. [To increase bone density faster and stronger].
    MMW Fortschr Med; 2005 May 05; 147(18):44-5. PubMed ID: 15934589
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Alendronate (Fosamax) and risedronate (Actonel) revisited.
    Med Lett Drugs Ther; 2005 Apr 25; 47(1207):33-5. PubMed ID: 15843782
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.
    Iwamoto J, Takeda T, Sato Y.
    Curr Med Res Opin; 2006 May 25; 22(5):919-28. PubMed ID: 16709313
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
    Brecht JG, Kruse HP, Möhrke W, Oestreich A, Huppertz E.
    Int J Clin Pharmacol Res; 2004 May 25; 24(1):1-10. PubMed ID: 15575171
    [Abstract] [Full Text] [Related]

  • 13. [Osteoporosis therapy. Bisphosphonates compared].
    MMW Fortschr Med; 2003 Mar 27; 145(13):60. PubMed ID: 15101545
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis.
    Cramer JA, Amonkar MM, Hebborn A, Altman R.
    Curr Med Res Opin; 2005 Sep 27; 21(9):1453-60. PubMed ID: 16197664
    [Abstract] [Full Text] [Related]

  • 16. [Men also need bone protection].
    MMW Fortschr Med; 2006 Nov 16; 148(46):48-9. PubMed ID: 17615790
    [No Abstract] [Full Text] [Related]

  • 17. Long-term experience with alendronate in the treatment of osteoporosis.
    Hochberg MC, Rizzoli R.
    Expert Opin Pharmacother; 2006 Jun 16; 7(9):1201-10. PubMed ID: 16732706
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Once-a-week alendronate (Fosamax).
    Med Lett Drugs Ther; 2001 Mar 19; 43(1100):26. PubMed ID: 11257718
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.